Ascentage Pharma Group International (AAPG) Accumulated Expenses: 2022-2024

Historic Accumulated Expenses for Ascentage Pharma Group International (AAPG) over the last 3 years, with Dec 2024 value amounting to $2.0 million.

  • Ascentage Pharma Group International's Accumulated Expenses was N/A to -$5.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was -$5.6 billion, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is 100.04% up from last year.
  • Latest data reveals that Ascentage Pharma Group International reported Accumulated Expenses of $2.0 million as of FY2024, which was up 100.04% from -$5.2 billion recorded in FY2023.
  • In the past 5 years, Ascentage Pharma Group International's Accumulated Expenses ranged from a high of $2.0 million in FY2024 and a low of -$17.7 billion during FY2022.
  • Over the past 3 years, Ascentage Pharma Group International's median Accumulated Expenses value was -$5.2 billion (recorded in 2023), while the average stood at -$7.6 billion.
  • Data for Ascentage Pharma Group International's Accumulated Expenses shows a peak YoY soared of 100.04% (in 2024) over the last 5 years.
  • Ascentage Pharma Group International's Accumulated Expenses (Yearly) stood at -$17.7 billion in 2022, then surged by 70.56% to -$5.2 billion in 2023, then skyrocketed by 100.04% to $2.0 million in 2024.